Shanghai Pharmaceuticals Holding Co., Ltd (HKG: 2607)

Market Cap	77.74B
Revenue (ttm)	301.73B
Net Income (ttm)	4.46B
Shares Out	n/a
EPS (ttm)	1.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Sep 17, 2024

Volume	3,556,191
Open	13.12
Previous Close	13.12
Day's Range	12.80 - 13.12
52-Week Range	10.04 - 14.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 26, 2025

About Shanghai Pharmaceuticals Holding

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, syste...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 48,164
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2607

Financial Performance

In 2023, Shanghai Pharmaceuticals Holding's revenue was 260.30 billion, an increase of 12.21% compared to the previous year's 231.98 billion. Earnings were 3.77 billion, a decrease of -32.92%.

Financial numbers in CNY